市場調查報告書

鐮狀細胞貧血症的檢驗和篩檢- 全球市場預測(2019年∼2027年)

Sickle Cell Anemia Testing and Screening - Global Market Outlook (2019-2027)

出版商 Stratistics Market Research Consulting 商品編碼 956072
出版日期 內容資訊 英文 187 Pages
商品交期: 2-3個工作天內
價格
鐮狀細胞貧血症的檢驗和篩檢- 全球市場預測(2019年∼2027年) Sickle Cell Anemia Testing and Screening - Global Market Outlook (2019-2027)
出版日期: 2020年08月01日內容資訊: 英文 187 Pages
簡介

全球鐮狀細胞貧血症檢驗及篩檢的市場規模在2019年估算為2億2,304萬美元,2027年之前達到3億9,779萬美元,在預測期間內預計將以7.5%的年複合成長率成長。市場成長的推動因素包括篩查產品使用量的增加,減少鐮狀紅斑負擔策略的實施以及全球鐮狀紅斑的患病率增加。但是,與鐮狀紅斑篩查和測試相關的基礎設施挑戰限制了市場的增長。

本報告提供鐮狀細胞貧血症的檢驗和篩檢市場調查,提供市場概要,市場成長要素及阻礙因素分析,各年齡·各技術·各類型·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介會等全面性資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 技術分析
  • 新興市場
  • Covid-19的影響

第4章 波特的五力分析

第5章 全球鐮狀細胞貧血症的檢驗和篩檢的市場:各年齡

  • 成人篩檢(25歲以上∼不滿60歲)
  • (新生兒篩檢不滿12個月)
  • 其他年齡層(1歲以上∼不滿25歲,60歲以上)

第6章 全球鐮狀細胞貧血症的檢驗和篩檢的市場:各技術

  • 臨床現場即時檢測(POCT)
  • 血紅素電泳
  • 高效液相層析(HPLC)

第7章 全球鐮狀細胞貧血症的檢驗和篩檢的市場:各部門類型

  • 企業實驗室
  • 政府研究所
  • 官民合作關係(PPP)
  • 私人實驗室

第8章 全球鐮狀細胞貧血症的檢驗和篩檢的市場: 各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和近東及非洲的其他中東的地區

第9章 主要發展

  • 契約,夥伴關係,合作,合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他主要策略

第10章 企業簡介

  • Request A Test, Ltd.
  • Halcyon Biomedical Incorporated
  • Silver Lake Research Corporation
  • Streck, Inc.
  • Daktari Diagnostics
  • Biomedomics Inc.
  • Laboratory Corporation of America Holdings
  • PerkinElmer Inc.
  • Quest Diagnostics
  • Hemotype
  • Hemex Health
  • Bio-Rad Laboratories, Inc.
目錄

According to Stratistics MRC, the Global Sickle Cell Anemia Testing and Screening Market is accounted for $223.04 million in 2019 and is expected to reach $397.79 million by 2027 growing at a CAGR of 7.5% during the forecast period. Some of the key factors propelling the market growth include increase the uptake of screening products, increasing implementation of strategies to minimize the sickle cell disease burden, rising prevalence of sickle cell disease across the globe. However, infrastructural challenges associated with screening and diagnosis of sickle cell disease is restricting the market growth.

Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.

By age group, the adult screening segment is expected to grow at the significant rate throughout the forecast period. SCD treatment and management differ at distinct levels based on the patient's stage. This is attributed to the observed differences in the SCD associated pain, comorbidities, psychosocial impact, and healthcare expenditure with respect to the age group of sickle cell anemia patients. Additionally, increasing number of research activities are aimed at analyzing the impact of age-specific healthcare strategies on improving the management of sickle cell disease population. Employment of targeted screening with respect to age group of sickle cell patients has also extended life span of these patients into adulthood.

On the basis of geography, Asia Pacific region is expected to have considerable market growth during the forecast period. Rising acknowledgment and recognition of sickle cell screening targeted towards newborns have been recently witnessed in the Asia Pacific countries, specifically India. Additionally, these developing countries are devising strategies to address challenges associated with newborn screening programs across high-income countries, which is inclusive of streamlining follow-up screening or diagnosis. This is set to offer a significant momentum to the Asia Pacific market in the near future.

Some of the key players in Sickle Cell Anemia Testing and Screening Market include Request A Test, Ltd., Halcyon Biomedical Incorporated, Silver Lake Research Corporation, Streck, Inc., Daktari Diagnostics, Biomedomics Inc., Laboratory Corporation of America Holdings, PerkinElmer Inc., Quest Diagnostics, Hemotype, Hemex Health, and Bio-Rad Laboratories, Inc.

Age Groups Covered:

  • Adult Screening (25 to 60 Years)
  • Newborn Screening (12 Months and Below)
  • Other Age Groups (1 to 25 & Above 60 Years)

Technologies Covered:

  • Point-of-Care Tests
  • Hemoglobin Electrophoresis
  • High-performance Liquid Chromatography (HPLC)

Sector Types Covered:

  • Corporate Labs
  • Government Labs
  • Public-Private-Partnerships (PPP)
  • Private Labs

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Sickle Cell Anemia Testing and Screening Market, By Age Group

  • 5.1 Introduction
  • 5.2 Adult Screening (25 to 60 Years)
  • 5.3 Newborn Screening (12 Months and Below)
  • 5.4 Other Age Groups (1 to 25 & Above 60 Years)

6 Global Sickle Cell Anemia Testing and Screening Market, By Technology

  • 6.1 Introduction
  • 6.2 Point-of-Care Tests
    • 6.2.1 Paper-Based Rapid Diagnostics
    • 6.2.2 Lateral Flow Immunoassay
  • 6.3 Hemoglobin Electrophoresis
    • 6.3.1 Isoelectric Focusing
  • 6.4 High-performance Liquid Chromatography (HPLC)

7 Global Sickle Cell Anemia Testing and Screening Market, By Sector Type

  • 7.1 Introduction
  • 7.2 Corporate Labs
  • 7.3 Government Labs
  • 7.4 Public-Private-Partnerships (PPP)
  • 7.5 Private Labs

8 Global Sickle Cell Anemia Testing and Screening Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Request A Test, Ltd.
  • 10.2 Halcyon Biomedical Incorporated
  • 10.3 Silver Lake Research Corporation
  • 10.4 Streck, Inc.
  • 10.5 Daktari Diagnostics
  • 10.6 Biomedomics Inc.
  • 10.7 Laboratory Corporation of America Holdings
  • 10.8 PerkinElmer Inc.
  • 10.9 Quest Diagnostics
  • 10.10 Hemotype
  • 10.11 Hemex Health
  • 10.12 Bio-Rad Laboratories, Inc.

List of Tables

  • Table 1 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Region (2018-2027) ($MN)
  • Table 2 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)
  • Table 3 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)
  • Table 4 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)
  • Table 5 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)
  • Table 6 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)
  • Table 7 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)
  • Table 8 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)
  • Table 9 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)
  • Table 10 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)
  • Table 11 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)
  • Table 12 Global Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)
  • Table 13 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)
  • Table 14 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)
  • Table 15 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)
  • Table 16 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)
  • Table 17 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)
  • Table 18 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)
  • Table 19 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)
  • Table 20 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)
  • Table 21 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)
  • Table 22 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)
  • Table 23 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)
  • Table 24 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)
  • Table 25 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)
  • Table 26 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)
  • Table 27 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)
  • Table 28 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)
  • Table 29 North America Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)
  • Table 30 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)
  • Table 31 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)
  • Table 32 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)
  • Table 33 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)
  • Table 34 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)
  • Table 35 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)
  • Table 36 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)
  • Table 37 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)
  • Table 38 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)
  • Table 39 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)
  • Table 40 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)
  • Table 41 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)
  • Table 42 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)
  • Table 43 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)
  • Table 44 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)
  • Table 45 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)
  • Table 46 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)
  • Table 47 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)
  • Table 48 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)
  • Table 49 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)
  • Table 50 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)
  • Table 51 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)
  • Table 52 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)
  • Table 53 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)
  • Table 54 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)
  • Table 55 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)
  • Table 56 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)
  • Table 57 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)
  • Table 58 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)
  • Table 59 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)
  • Table 60 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)
  • Table 61 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)
  • Table 62 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)
  • Table 63 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)
  • Table 64 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)
  • Table 65 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)
  • Table 66 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)
  • Table 67 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)
  • Table 68 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)
  • Table 69 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)
  • Table 70 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)
  • Table 71 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)
  • Table 72 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)
  • Table 73 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)
  • Table 74 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)
  • Table 75 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)
  • Table 76 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)
  • Table 77 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)
  • Table 78 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)
  • Table 79 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)
  • Table 80 South America Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)
  • Table 81 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)
  • Table 82 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)
  • Table 83 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)
  • Table 84 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)
  • Table 85 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)
  • Table 86 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)
  • Table 87 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)
  • Table 88 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)
  • Table 89 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)
  • Table 90 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)
  • Table 91 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)
  • Table 92 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)
  • Table 93 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)
  • Table 94 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)
  • Table 95 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)
  • Table 96 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)
  • Table 97 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)
  • Table 98 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)
  • Table 99 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)
  • Table 100 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)
  • Table 101 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)
  • Table 102 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)